| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |